参考文献/References:
[1] Wang J, Sakariassen PO, Tsinkalovsky, O, et al. CD133
negative glioma cells form tumors in nude rats and give rise
to CD133 positive cells [J]. Int J Cancer, 2008, 122(4): 761-
768.
[2] Joo KM, Kim SY, Jin X, et al. Clinical and biological impli-
cations of CD133-positive and CD133-negative cells in
glioblastomas [J]. Lab Invest, 2008, 88(8): 808-815.
[3] Wang GP, Han XF. CD9 modulates proliferation of human
glioblastoma cells via epidermal growth factor receptor
signaling [J]. Mol Med Rep, 2015, 12(1): 1381-1386.
[4] Podergajs N, Motaln H, Rajcevic U, et al. Transmembrane
protein CD9 is glioblastoma biomarker, relevant for mainte-
nance of glioblastoma stem cells [J]. Oncotarget, 2016, 7(1):
593-609.
[5] Mohanan V, Temburni MK, Kappes JC, et al. L1CAM
stimulates glioma cell motility and proliferation through the
fibroblast growth factor receptor [J]. Clin Exp Metastasis,
2013, 30(4): 507-520.
[6] Held-Feindt J, Schmelz S, Hattermann K, et al. The neural
adhesion molecule L1CAM confers chemoresistance in
human glioblastomas [J]. Neurochem Int, 2012, 61(7):
1183-1191.
[7] Schafer H, Dieckmann C, Korniienko O, et al. Combined
treatment of L1CAM antibodies and cytostatic drugs
improve the therapeutic response of pancreatic and ovarian
carcinoma [J]. Cancer Lett, 2012, 319(1): 66-82.
[8] Pietras A, Katz AM, Ekstrom EJ, et al. Osteopontin-CD44
signaling in the glioma perivascular niche enhances cancer
stem cell phenotypes and promotes aggressive tumor growth
[J]. Cell Stem Cell, 2014, 14(3): 357-369.
[9] Mooney KL, Choy W, Sidhu S, et al. The role of CD44 in
glioblastoma multiforme [J]. J Clin Neurosci, 2016, 34: 1-5.
[10] Yoshida T, Matsuda Y, Naito Z, et al. CD44 in human
glioma correlates with histopathological grade and cell
migration [J]. Pathol Int, 2012, 62(7): 463-470.
[11] Parry PV, Engh JA. CD90 is identified as a marker for
cancer stem cells in high-grade gliomas using tissue
microarrays [J]. Neurosurgery, 2012, 70(4): N23-24.
[12] Shaikh MV, Kala M, Nivsarkar M. CD90 a potential cancer
stem cell marker and a therapeutic target [J]. Cancer
Biomark, 2016, 16(3): 301-307.
[13] Tchoghandjian A, Baeza N, Colin C, et al. A2B5 cells from
human glioblastoma have cancer stem cell properties [J].
Brain Pathol, 2010, 20(1): 211-221.
[14] Dahlrot RH, Hermansen SK, Hansen S, et al. What is the
clinical value of cancer stem cell markers in gliomas [J]?
Int J Clin Exp Pathol, 2013, 6(3): 334-348.
[15] Andolfo I, Liguori L, De Antonellis P, et al. The micro-RNA
199b-5p regulatory circuit involves Hes1, CD15, and
epigenetic modifications in medulloblastoma [J]. Neuro
Oncol, 2012, 14(5): 596-612.
[16] Mao XG, Zhang X， Xue XY, et al. Brain tumor stem-like
cells identified by neural stem cell marker CD15 [J]. Transl
Oncol, 2009, 2(4): 247-257.
[17] Hu T, Zhou R, Zhao Y, et al. Integrin alpha6/Akt/Erk
signaling is essential for human breast cancer resistance to
radiotherapy [J]. Sci Rep, 2016, 6: 33376.
[18] Velpula KK, Rehman AA, Chelluboina B, et al. Glioma stem
cell invasion through regulation of the nterconnected ERK,
integrin alpha6 and N-cadherin signaling pathway [J]. Cell
Signal, 2012, 24(11): 2076-2084.
[19] Ying M, Tilghman J, Wei Y, et al. Kruppel-like factor-9
(KLF9) inhibits glioblastoma stemness through global
transcription repression and integrin alpha6 inhibition [J]. J
Biol Chem, 2014, 289(47): 32742-32756.
[20] Jin Y, Bin ZQ, Qiang H, et al. ABCG2 is related with the
grade of glioma and resistance to mitoxantone, a chemothe-
rapeutic drug for glioma [J]. J Cancer Res Clin Oncol, 2009,
135(10): 1369-1376.
[21] Wee B, Pietras A, Ozawa T, et al. ABCG2 regulates self-
renewal and stem cell marker expression but not tumorige-
nicity or radiation resistance of glioma cells [J]. Sci Rep,
2016, 6: 25956.
[22] Bleau AM, Huse JT, Holland EC. The ABCG2 resistance
network of glioblastoma [J]. Cell Cycle, 2009, 8(18): 2936-
2944.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(04):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(04):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(04):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(04):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(04):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]孟 亮 陈谦学 余小祥 涂 勤 王跃飞 樊 文 罗才奎.MS-275对原代培养的胶质瘤细胞及其干细胞生物学行为和耐药性的影响[J].中国临床神经外科杂志,2020,(06):381.[doi:10.13798/j.issn.1009-153X.2020.06.014]
MENG Liang,CHEN Qian-xue,YU Xiao-xiang,et al.MS-275 regulates biological behavior and drug resistance of primary cultured glioma cells and glioma stem cells through PI3K/Akt signaling pathway[J].,2020,(04):381.[doi:10.13798/j.issn.1009-153X.2020.06.014]
[12]任光辉 李武雄 齐利豪.胶质瘤干细胞外泌体通过PI3K/Akt信号通路促进胶质瘤U87细胞侵袭、迁移[J].中国临床神经外科杂志,2021,26(03):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]
REN Guang-hui,LI Wu-xiong,QI Li-hao.Glioma stem cell-derived exosomes promote glioma U87 cell invasion and migration through PI3K/Akt signaling pathway[J].,2021,26(04):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]
[13]刘祯,赵海洋,吴环立,等.敲低WTAP表达抑制脑胶质瘤干细胞的增殖、迁移和侵袭[J].中国临床神经外科杂志,2023,28(04):263.[doi:10.13798/j.issn.1009-153X.2023.04.011]
LIU Zhen,ZHAO Hai-yang,WU Huan-li,et al.Knockdown of WTAP expression inhibites proliferation, migration, and invasion of glioma stem cells[J].,2023,28(04):263.[doi:10.13798/j.issn.1009-153X.2023.04.011]